Arabinosyladenine_Triphosphate

Category

Arabinosyladenine_Triphosphate




Useful info

Arabinosyladenine_Triphosphate Brand names, Arabinosyladenine_Triphosphate Analogs

Arabinosyladenine_Triphosphate Brand Names Mixture

  • No information avaliable
  • Arabinosyladenine_Triphosphate Chemical_Formula

    C10H15N5O5

    Arabinosyladenine_Triphosphate RX_link

    http://www.rxlist.com/cgi/generic3/vidarabine.htm

    Arabinosyladenine_Triphosphate fda sheet

    Arabinosyladenine_Triphosphate msds (material safety sheet)

    Arabinosyladenine_Triphosphate Synthesis Reference

    No information avaliable

    Arabinosyladenine_Triphosphate Molecular Weight

    285.257 g/mol

    Arabinosyladenine_Triphosphate Melting Point

    No information avaliable

    Arabinosyladenine_Triphosphate H2O Solubility

    No information avaliable

    Arabinosyladenine_Triphosphate State

    Solid

    Arabinosyladenine_Triphosphate LogP

    -2.115

    Arabinosyladenine_Triphosphate Dosage Forms

    No information avaliable

    Arabinosyladenine_Triphosphate Indication

    For treatment of chickenpox - varicella, herpes zoster and herpes simplex

    Arabinosyladenine_Triphosphate Pharmacology

    Vidarabine is a synthetic purine nucleoside analogue with in vitro and in vivo inhibitory activity against herpes simplex virus types 1 (HSV-1), 2 (HSV-2), and varicella-zoster virus (VZV). The inhibitory activity of Vidarabine is highly selective due to its affinity for the enzyme thymidine kinase (TK) encoded by HSV and VZV. This viral enzyme converts Vidarabine into Vidarabine monophosphate, a nucleotide analogue. The monophosphate is further converted into diphosphate by cellular guanylate kinase and into triphosphate by a number of cellular enzymes. in vitro, Vidarabine triphosphate stops replication of herpes viral DNA. When used as a substrate for viral DNA polymerase, Vidarabine triphosphate competitively inhibits dATP leading to the formation of 'faulty' DNA. This is where Vidarabine triphosphate is incorporated into the DNA strand replacing many of the adenosine bases. This results in the prevention of DNA synthesis, as phosphodiester bridges can longer to be built, destabilizing the strand.

    Arabinosyladenine_Triphosphate Absorption

    No information avaliable

    Arabinosyladenine_Triphosphate Toxicity

    No information avaliable

    Arabinosyladenine_Triphosphate Patient Information

    No information avaliable

    Arabinosyladenine_Triphosphate Organisms Affected

    Human Herpes Viruses